Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC12A9 (Solute carrier family 12 member 9) encodes a protein that is a putative member of the cation-chloride cotransporter family, functioning as a transporter involved in potassium and chloride ion homeostasis and transmembrane transport[1][2][3][5]. Although the exact physiological role remains unclear, evidence suggests involvement in lysosomal ion flux and osmoregulation[2]. Genome-wide association studies have implicated SLC12A9 in cardiac function through genetic association with resting heart rate, while altered expression is linked to poor prognosis in certain cancers, such as uveal melanoma and colorectal cancer[1]. SLC12A9 is considered a transporter protein and a potential emerging therapeutic and prognostic target in disease[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 12 member 9 (SLC12A9).